Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind randomized comparison of Gynevac lactobacillus vaccine vs ofloxacin in chronic prostatitis
2004-004003-38Phase 3Completed
- Sponsor
- Vakcina
- Start
- Nov 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gynevac in chronic prostatitis (CP) and benign prostatic hyperplasia (BPH) (2 arms), sponsored by Vakcina. Primary endpoints: UWSS score change at 1 week after treatment and UWSS score change at 6 months after treatment. Started Nov 2004; status: completed.
02
Drugs
gynevac
03
Conditions
chronic prostatitis (CP)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2004-004003-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004003-38.